Roost H-P, Gassner M, Grize L, Wüthrich B, Sennhauser F H, Varonier H S, Zimmermann H, Braun-Fahrländer Ch
Swiss Federal Office of Public Health, Division of Epidemiology and Infectious Diseases, CH-3003 Bern, Switzerland.
Pediatr Allergy Immunol. 2004 Oct;15(5):401-7. doi: 10.1111/j.1399-3038.2004.00192.x.
The prevalence of asthma and allergic disease has increased in many countries. It has been proposed that vaccinations may contribute to the development of allergic disease by reducing clinical infections in infancy or through the direct IgE-inducing effects of the vaccines. Evidence for a potential role of immunizations in the development of allergic disease is scarce. Therefore the objective was to study the associations between vaccinations against measles, mumps and rubella (MMR), natural infections of these diseases and atopic sensitization to indoor and outdoor allergens and allergic symptoms in schoolchildren. The cross-sectional study including 1537 8(th) grade school children aged 13-15 years living in 10 communities across Switzerland was organized in the framework of an environmental health surveillance program within the School Health Services (Swiss Surveillance Program of Childhood Asthma and Allergies with respect to Air Pollution and Climate, SCARPOL). Main outcome measures were asthma and sneezing during pollen season assessed by parental questionnaires and atopic sensitization determined by IgE concentrations to various allergens. It was found that parents' reported history of measles or mumps was associated with a stronger immune response than two or more vaccinations against the respective infection (measles: geometric mean IgG titers (GMT) lU/ml (95% Cl) 2.8 (2.0-3.9) vs. 1.2 (1.0-1.4), mumps: GMT PE/ml (95% Cl) 16.3 (13.9-19.1) vs. 8.5 (6.1-11.7). With respect to atopic sensitization similar associations for exposure by natural MMR-infections or MMR-vaccinations were found: measles: OR (95% Cl) 1.02 (0.53-1.96) vs. 1.22 (0.69-2.16), mumps: 0.59 (0.38-0.93) vs. 0.79 (0.49-1.27), rubella: 0.93 (0.61-1.43) vs. 0.95 (0.66-1.37), respectively. Inverse relationships were found between the risk of asthma and a positive disease history or vaccination of measles 0.36 (0.14-0.91) vs. 0.45 (0.21-0.98) or a positive serum titer against measles 0.65 (0.35-1.20). From the present study can be concluded that exposure by MMR-vaccinations or natural MMR-infections in childhood does not increase the risk of sensitization to common allergens as well as to allergic respiratory diseases. MMR-vaccinations or natural MMR-infections are therefore an unlikely factor contributing to the increase in atopic disease in developed countries.
许多国家哮喘和过敏性疾病的患病率都有所上升。有人提出,疫苗接种可能通过减少婴儿期的临床感染或通过疫苗直接诱导IgE的作用,导致过敏性疾病的发生。关于免疫接种在过敏性疾病发生中潜在作用的证据很少。因此,本研究的目的是探讨麻疹、腮腺炎和风疹(MMR)疫苗接种、这些疾病的自然感染与学龄儿童对室内和室外过敏原的特应性致敏以及过敏症状之间的关联。这项横断面研究纳入了瑞士10个社区的1537名13 - 15岁的八年级学龄儿童,该研究是在学校卫生服务机构的环境卫生监测项目(瑞士儿童哮喘和过敏与空气污染和气候的监测项目,SCARPOL)框架内组织开展的。主要观察指标包括通过家长问卷评估的花粉季节哮喘和打喷嚏情况,以及通过针对各种过敏原的IgE浓度测定的特应性致敏情况。研究发现,家长报告的麻疹或腮腺炎病史与比相应感染的两次或更多次疫苗接种更强的免疫反应相关(麻疹:几何平均IgG滴度(GMT)lU/ml(95%可信区间)2.8(2.0 - 3.9)vs. 1.2(1.0 - 1.4),腮腺炎:GMT PE/ml(95%可信区间)16.3(13.9 - 19.1)vs. 8.5(6.1 - 11.7))。关于特应性致敏,发现自然MMR感染或MMR疫苗接种的暴露情况有类似关联:麻疹:比值比(OR)(95%可信区间)1.02(0.53 - 1.96)vs. 1.22(0.69 - 2.16),腮腺炎:0.59(0.38 - 0.93)vs. 0.79(0.49 - 1.27),风疹:0.93(0.61 - 1.43)vs. 0.95(0.66 - 1.37)。在哮喘风险与麻疹的阳性疾病史或疫苗接种之间发现了相反的关系(0.36(0.14 - 0.91)vs. 0.45(0.21 - 0.98)),或者与麻疹的阳性血清滴度之间(0.65(0.35 - 1.20))。从本研究可以得出结论,儿童期MMR疫苗接种或自然MMR感染不会增加对常见过敏原以及过敏性呼吸道疾病致敏的风险。因此,MMR疫苗接种或自然MMR感染不太可能是导致发达国家特应性疾病增加的因素。